WSGR logoWSGR logo
Martin J. Waters
Partner
Corporate
San Diego

D858-350-2308

Download vCard
LinkedIn
Open PDF
  • A Proven Company Builder

    With more than 25 years of experience providing corporate and securities counsel, Marty has been instrumental in starting, building, and shepherding numerous emerging growth companies through IPOs or strategic partnerships.

  • Southern California Focus

    A founding partner of the San Diego office and Southern California corporate practice, Marty leads the firm's efforts in representing public and private growth companies in San Diego, Orange County, and Los Angeles.

  • A Recognized Practitioner

    Ranked Band 1 by Chambers USA for his corporate work in Southern California, Marty has been recognized as a leading corporate attorney in multiple editions of Chambers USA, as well as, San Diego Metropolitan Magazine, IPO Journal, and LMG Life Sciences.

Martin (Marty) Waters is a corporate and securities partner in the San Diego office. He is a founding partner of the firm's San Diego office and Southern California corporate practice. He was a partner in the Palo Alto office until opening the San Diego office in 2004. He is a current member of the firm's board of directors.

Marty is a proven company builder with more than 25 years of experience providing corporate and securities counsel to high growth private and public companies. He has been instrumental in starting, building, and shepherding numerous emerging growth life sciences and technology companies through IPOs or strategic partnerships. Marty also represents several public companies in a general counsel capacity, as well as investment banks and placement agents in PIPEs and public offerings. Marty has counseled issuers and underwriters in more than 50 offerings.

Recognized in Chambers USA: America's Leading Lawyers for Business since 2011, Marty is “highly respected for the superlative quality of the corporate counsel he offers corporate clients.” Sources describe him as a “a trusted partner” who “consistently delivers great advice” with a “specialty in managing complex and difficult stalemates.”

Experience

Martin (Marty) Waters is a corporate and securities partner in the San Diego office. He is a founding partner of the firm's San Diego office and Southern California corporate practice. He was a partner in the Palo Alto office until opening the San Diego office in 2004. He is a current member of the firm's board of directors.

Marty is a proven company builder with more than 25 years of experience providing corporate and securities counsel to high growth private and public companies. He has been instrumental in starting, building, and shepherding numerous emerging growth life sciences and technology companies through IPOs or strategic partnerships. Marty also represents several public companies in a general counsel capacity, as well as investment banks and placement agents in PIPEs and public offerings. Marty has counseled issuers and underwriters in more than 50 offerings.

Recognized in Chambers USA: America's Leading Lawyers for Business since 2011, Marty is “highly respected for the superlative quality of the corporate counsel he offers corporate clients.” Sources describe him as a “a trusted partner” who “consistently delivers great advice” with a “specialty in managing complex and difficult stalemates.”

Focus Areas
Recent Insights
Client Highlights
Wilson Sonsini Advises Vertos Medical Inc. in Acquisition by Stryker
On August 22, 2024, Stryker, a global leader in medical technologies, announced a definitive agreement to acquire Vertos Medical Inc., a privately held company providing a minimally invasive solution for treating chronic lower back pain caused by lumbar spinal stenosis. Wilson Sonsini Goodrich & Rosati advised Vertos on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Neo Medical SA on Series B and $68 Million Equity Investment
On September 17, 2024, Neo Medical SA (Neo), a Swiss technology company specializing in spine surgery, announced the successful completion of its Series B financing round, including the conversion of existing shareholder loans. With this financing round, Neo has secured an additional equity investment of up to $68 million to accelerate its global growth. Led by Gyrus Capital SA (Gyrus), alongside the participation of existing investors, including founders Vincent Lefauconnier and Jonas Larsson, this round is one of the most significant in the spine industry in the last decade. The proceeds will be used to increase Neo’s market share in key regions with an immediate focus on expanding the U.S. business, deploying new, complementary, and disruptive products, and enhancing the capabilities of its unique AIdriven augmented reality intraoperative data platform, ADVISE™.
Learn More
View All
Recent Events
Affiliated Programs
Octane’s Ophthalmology Tech Forum 2024
Wilson Sonsini is proud to support Octane’s Ophthalmology Tech Forum 2024 in Newport Beach.
Learn More
WSGR Events
Wilson Sonsini’s 31st Annual Medical Device & Digital Health Conference
Wilson Sonsini Goodrich & Rosati’s 31st Annual Medical Device & Digital Health Conference will address topics of critical importance to medical device and digital health companies today, including key healthcare regulatory considerations, the relationship between intellectual property and valuation, a look back at 2023’s fundraising and deals, and how 2024 is shaping up along with partnering strategies in the current market.
Learn More
View All
WSGR logo
Copyright © 2024 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.